SBC Medical Group Holdings Incorporated (SBCWW) Stock Price & Analysis
SBC Medical Group Holdings Incorporated (SBCWW) closed at USD 0.42 on Thursday, October 15, 2026, up 0.00% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0.42; the Oct 15, 2026 session ranged USD 0.42–0.42 on volume of 2,168 shares. Market capitalization is —, with a 52-week range of USD 0.42–0.42 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:11 UTC.
Also available as compact Markdown for AI agents: nexqual.com/SBCWW.md
Key facts (SBCWW)
- Insider open-market sales, last ~7 months: 2 Form 4 filings, $10.8M; 2 not under a Rule 10b5-1 plan ($10.8M).
- Analysts: None.
Financials (SEC 10-K) (SBCWW)
| USD | FY2024 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $194M | $205M | $174M |
| Gross profit | $137M | $156M | $127M |
| Operating income | $70.7M | $70.3M | $67.5M |
| Net income | $39.4M | $46.6M | $51.0M |
| EPS (diluted) | $0.42 | $0.48 | $0.50 |
| Free cash flow | $42.1M | $18.0M | $23.3M |
| Gross margin | 70.9% | 76.0% | 73.3% |
| Operating margin | 36.5% | 34.2% | 38.9% |
| Net margin | 20.3% | 22.7% | 29.4% |
| Revenue growth | — | +6.1% | -15.5% |
| Cash + short-term investments | $103M | $125M | $164M |
| Total debt | — | $6.9M | $43.1M |
Fiscal years end Dec. EPS is split-adjusted.
Insider sales (SEC Form 4, open-market, last ~7 months) (SBCWW)
0 of 2 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan |
|---|---|---|---|---|---|---|
| 2026-04-28 | Aikawa Yoshiyuki | Chairman and CEO | 465,000 | $1.4M | 0.6% | No |
| 2026-04-21 | Aikawa Yoshiyuki | Chairman and CEO | 3,100,000 | $9.4M | 3.7% | No |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Analysts (SBCWW)
Consensus None.
Key Statistics (as of October 16, 2026 at 05:11 UTC)
| Price | USD 0.42 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.42 |
| Open | USD 0.17 |
| Day Range | USD 0.42 – 0.42 |
| 52-Week Range | USD 0.42 – 0.42 |
| Volume | 2,168 shares |
| Market Cap | — |
| Exchange | NCM |
Analyst Ratings (SBCWW)
Wall Street analysts rate SBCWW "None", per Nexqual as of October 16, 2026 at 05:11 UTC.
| Consensus Rating | None |
|---|
Earnings (SBCWW)
| Revenue Estimate | $48.89M |
|---|
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Financials & Fundamentals (SBCWW)
| Total Revenue | $175.17M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +13.40% |
| Gross Margin | +71.85% |
| Operating Margin | +38.55% |
| Profit Margin | +27.99% |
| ROE | +18.91% |
| Debt / Equity | 0.17 |
| Current Ratio | 3.31 |
| Total Cash | $184.62M |
| Total Debt | $48.23M |
| Free Cash Flow (fiscal year ended Dec 2025, SEC 10-K) | $23.27M (13.4% of revenue) |
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Financial Health Score (SBCWW)
Nexqual rates SBC Medical Group Holdings Incorporated's overall financial health "Solid" across five dimensions, as of October 16, 2026 at 05:11 UTC.
| Growth | Critical — Revenue -15% YoY (annual), sharp decline |
|---|---|
| Profitability | Strong — Gross margin 72%, operating 39% |
| Balance Sheet | Strong — $185M cash vs $48M debt, net cash position |
| Cash Flow | Solid — FCF $23M (FY ended Dec 2025, 10-K), 13% margin |
| Efficiency | Solid — ROE 19%, ROA 11.3% |
Ownership (SBCWW)
| Float | 18.10M |
|---|
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Leadership (SBCWW)
SBC Medical Group Holdings Incorporated is led by Yoshiyuki Aikawa (age 54), Chairman & CEO, per Nexqual as of October 16, 2026 at 05:11 UTC.
| Chairman & CEO | Yoshiyuki Aikawa (age 54) |
|---|---|
| COO, CFO & Director | Yuya Yoshida (age 45) |
| Chief Strategy Officer | Miki Yamazaki (age 39) |
| Chief Marketing Officer | Shinya Inoue |
| COO of SBC Medical Group Co., Ltd. (Japan) | Hiroyuki Miya |
Major Backers & Investors (SBCWW)
Notable institutional backers of SBC Medical Group Holdings Incorporated include Decagon Asset Management LLP, Aristeia Capital, LLC, Polar Asset Management Partners Inc., according to Nexqual as of October 16, 2026 at 05:11 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Decagon Asset Management LLP | 8.22% |
| Aristeia Capital, LLC | 4.61% |
| Polar Asset Management Partners Inc. | 3.78% |
| MMCAP International, Inc. SPC | 2.87% |
| Weiss Asset Management Lp | 1.99% |
| Saba Capital Management, L.P. | 1.82% |
| Context Capital Management, LLC | 1.81% |
| Yakira Capital Management, Inc. | 1.8% |
Source: Nexqual, October 16, 2026 at 05:11 UTC.
From SBC Medical Group Holdings Incorporated's Latest SEC 10-K Filing (filed 2026-03-27)
Key Strengths & Strategy (as disclosed to the SEC)
- SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore.
- The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procurement.
- It also provides loyalty program management, labor and function supporting, and management consulting services; and IT software solutions, as well as engages in franchising activities; and distributes medical equipment and devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale to clinic customers.
- Further, it owns and operates treatment centers under the SBC brand.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SHMDW | SCHMID Group N.V. Warrants | USD 0.6 | ▼ 22.18% |
| ANNAW | AleAnna, Inc. Warrant | USD 0.24 | ▼ 0.04% |
| SDSTW | Stardust Power Inc. | USD 0.07 | ▼ 3.99% |
| DRTSW | Alpha Tau Medical Ltd. Warrant | USD 2.99 | ▼ 17.4% |
| SLXNW | Biomotion Sciences Warrant | USD 0.01 | ▲ 0% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:11 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt